Bariatric Surgery in Turkey with Fatty Liver or Abnormal Liver Tests: Can the Operation Go Ahead?

Being told that you have fatty liver or abnormal liver blood tests before bariatric surgery can be worrying. Many international patients want to know whether an operation in Turkey must be cancelled, delayed, or changed because of a liver-related finding.

In Short

Fatty liver or mildly abnormal liver tests do not automatically prevent bariatric surgery. Surgery may be considered when assessment does not show advanced fibrosis, cirrhosis, clinically significant portal hypertension, or impaired liver function. Persistent or unexplained abnormalities need further evaluation, and suitability should be decided through an individualized multidisciplinary medical assessment.

Does fatty liver automatically prevent bariatric surgery?

No. Patients with metabolic dysfunction-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease (NAFLD), or steatohepatitis may be considered for bariatric surgery if they otherwise meet the appropriate eligibility criteria.

For eligible patients without advanced liver disease, bariatric surgery may improve obesity-related metabolic conditions and can reduce liver steatosis and inflammation. Some patients may also experience improvement in liver fibrosis, although the extent of improvement varies. Surgery should not be presented as a guaranteed treatment for liver disease.

Fatty liver is common in people living with obesity, insulin resistance, type 2 diabetes, and other metabolic conditions. The presence of fat in the liver is not the same as cirrhosis. Before surgery, the clinical team needs to establish how advanced the liver condition is and whether another cause could explain the abnormal test results.

Why abnormal liver tests need further evaluation

Liver tests provide useful information, but they do not provide a complete diagnosis on their own. ALT, AST, GGT, bilirubin, albumin, platelet count, and INR may each contribute to the assessment, but they should be interpreted alongside medical history, examination, and other investigations.

A raised ALT or AST may occur with fatty liver, but persistent abnormalities can have other causes. These can include medication effects, alcohol-related liver disease, viral hepatitis, autoimmune liver conditions, muscle-related problems, or other medical issues. A low platelet count, abnormal bilirubin, low albumin, or prolonged INR may raise concerns about liver function or portal hypertension and require careful review.

A mildly raised liver enzyme should not automatically prevent surgery. Equally, a normal ALT does not by itself show that surgery is safe or exclude significant liver disease. The overall liver assessment is more important than any single blood-test result.

What doctors may assess before surgery

The purpose of preoperative liver assessment is to determine whether surgery is reasonably safe and whether a liver condition needs treatment, monitoring, or specialist input first. The exact tests depend on medical history and initial findings, but the evaluation may include:

• Repeat liver blood tests to establish whether an abnormality is persistent.
• A review of alcohol intake, prescribed medicines, supplements, and other possible causes of abnormal results.
• Assessment of diabetes, obesity-related liver disease, and other metabolic conditions.
• Non-invasive fibrosis risk assessment using blood-based scores or other validated methods.
• Ultrasound or other appropriate liver imaging when clinically indicated.
• Assessment for signs of cirrhosis, portal hypertension, or impaired liver function.
• Referral to a hepatologist or gastroenterologist when results are persistent, unclear, or concerning.

In selected cases, indeterminate or concerning findings may require more detailed evaluation. Occasionally, a liver biopsy may be considered. Not every patient with fatty liver needs a biopsy; this decision should be made by a qualified physician based on the complete clinical picture.

When bariatric surgery may be considered

Uncomplicated fatty liver or MASLD

If assessment suggests fatty liver without advanced fibrosis, cirrhosis, clinically significant portal hypertension, or impaired liver function, bariatric surgery may remain an option when the patient otherwise meets surgical criteria. This is the setting in which evidence for metabolic and liver-related benefit is strongest.

Candidacy still depends on the complete preoperative assessment, including nutritional, psychological, medical, anaesthetic, and surgical considerations.

Possible steatohepatitis or uncertain fibrosis

Some people have fatty liver with suspected inflammation or an unclear fibrosis stage. This does not necessarily mean surgery is impossible, but further testing may be needed before a safe decision can be made.

If non-invasive testing is indeterminate, or liver tests remain abnormal without an identified explanation, specialist review is particularly important. Significant liver disease can be present without obvious symptoms, so the surgical plan should not be based on symptoms alone.

Compensated cirrhosis

In carefully selected patients with compensated cirrhosis, bariatric surgery may sometimes be considered. This requires detailed multidisciplinary risk-benefit assessment involving a bariatric surgeon and liver specialist, preferably in an experienced high-volume centre.

The team should assess previous decompensation and whether clinically significant portal hypertension is present. The type and timing of surgery, anaesthetic risk, nutritional status, liver reserve, and postoperative monitoring require particular attention.

Evidence for bariatric surgery in cirrhosis is more limited than evidence in non-cirrhotic fatty liver disease. Decisions in this setting should therefore be individualized rather than based on a single liver-enzyme result or a general statement that surgery is safe.

Decompensated cirrhosis or significant portal hypertension

Decompensated cirrhosis means that liver disease has developed serious complications or loss of functional reserve. Clinically significant portal hypertension is also an important adverse risk factor. In these situations, complications from elective bariatric surgery may be substantially more likely.

Bariatric surgery is generally avoided in patients with decompensated cirrhosis unless it is considered in connection with liver transplantation or under exceptional circumstances by a highly specialized team. Ascites, encephalopathy, variceal bleeding, jaundice, significant clotting abnormalities, or other signs of decompensation require specialist liver assessment before elective surgery is planned.

Preparing for bariatric surgery in Turkey

If you are considering bariatric surgery in Turkey and have fatty liver or abnormal liver tests, send relevant medical information to the clinic as early as possible. A remote assessment does not replace an appropriate in-person evaluation, but complete records can help the team identify what further information may be needed before travel.

Useful documents may include recent blood-test results, abdominal imaging reports, previous gastroenterology or hepatology letters, a list of medicines and supplements, records of diabetes or blood-pressure treatment, and details of previous surgery. If you have been told that you have fibrosis or cirrhosis, provide the relevant reports rather than relying on a brief verbal description.

Ask how liver findings will be reviewed, whether hepatology input is available, what tests may be repeated before surgery, and how postoperative follow-up will be arranged after you return home. You should also understand which team will manage a liver-related concern if the assessment changes the surgical plan.

Travel arrangements should remain flexible until the operation has received medical approval. Surgery may need to be delayed while abnormal results are investigated or a specialist assesses the liver condition. This is a safety measure and does not necessarily mean treatment will be permanently declined.

What happens around the operation and recovery?

If the clinical team confirms that surgery can proceed, the usual perioperative process includes medical and anaesthetic assessment, medication review, nutritional planning, and discussion of potential risks. Liver disease may affect decisions about medication, bleeding risk, fluid management, nutrition, and postoperative observation.

Follow-up after surgery is important for both weight management and liver health. Ongoing monitoring may include nutritional status, diabetes, liver tests, and any pre-existing liver condition. A local doctor or liver specialist should remain involved after return home, particularly for people with fibrosis or cirrhosis.

Improvement in fatty liver is not assessed only by weight change or symptoms. Follow-up liver tests, imaging, or specialist review should be arranged according to individual medical needs. Patients should follow the dietary and medication instructions given by their treating team and should not stop prescribed medicines without medical advice.

Potential risks and why individual assessment matters

All major surgery has potential risks, and chronic liver disease can increase the risk of complications. Depending on the severity of liver disease, concerns can include bleeding or clotting problems, fluid complications, infection, kidney problems, impaired healing, or worsening liver function.

People with uncomplicated fatty liver may have a different risk profile from those with advanced fibrosis or cirrhosis. Within cirrhosis, compensated and decompensated disease are also very different clinical situations. Individual suitability must be determined by qualified clinicians who have reviewed the examination findings, liver disease stage, other medical conditions, and planned procedure.

Estexper Clinic can help coordinate an evaluation, but the final decision should be made through an appropriate multidisciplinary medical assessment.

Questions to ask your bariatric team

• What is the likely cause of my abnormal liver tests?
• Do my results suggest fatty liver only, advanced fibrosis, or cirrhosis?
• Do I need a hepatology or gastroenterology consultation before surgery?
• Has clinically significant portal hypertension been assessed?
• Could any of my medicines or supplements affect my liver tests or surgical risk?
• Should blood tests or imaging be repeated before I travel?
• How will my liver condition be monitored after surgery and after I return home?
• What findings could make the team delay or cancel the operation?

Medical References

1. Bariatric surgery in cirrhosis: Clinical Practice Update — American Gastroenterological Association.
2. AASLD Practice Guidance on the Clinical Assessment and Management of Nonalcoholic Fatty Liver Disease — American Association for the Study of Liver Diseases.
3. 2022 ASMBS and IFSO: Indications for Metabolic and Bariatric Surgery — American Society for Metabolic and Bariatric Surgery and International Federation for the Surgery of Obesity and Metabolic Disorders.
4. Overweight and obesity management: Medicines and surgery — National Institute for Health and Care Excellence.
5. Preoperative risk evaluation and optimization for patients with liver disease — Peer-reviewed review article available through PubMed Central.